Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
—
—
—
The Company is engaged in the pharmaceutical business. The Company offers products in various categories like sterile, non sterile, nutraceutical and otc products catering to lifestyle segment.
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
CORAL LABORATORIES LTD. - 524506 - Submission Of Annual Report For The Financial Year 2023-24 As Duly Approved By The Members Of The Company | Download
CORAL LABORATORIES LTD. - 524506 - Submission Of Annual Report For The Financial Year 2023-24 As Duly Approved By The Members Of The Company | Download
Final • Div/Share: ₹ 2
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant